Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen in irritable bowel syndrome
NL-OMON23097Active, not recruiting
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ketotifen in irritable bowel syndrome (IBS) (4 arms). Primary endpoint: Change in rectal sensitivity. Started Jun 2005; status: active, not recruiting.
02
Drugs
ketotifen
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NL-OMON23097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23097.